Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
1ROG:BIT
Roche Holding AG Genussscheine
347,10 €
+6,80%
(+22,10) 1D
4 მაი, 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ROG...
Open
347,10 €
High
347,10 €
Low
347,10 €
Mkt. cap
323,00 მლრ.
Avg. vol.
45,00
Volume
70,00
52-wk high
414,00 €
52-wk low
258,00 €
No. of employees
113 ათ.
News stories
From sources across the web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOთომას შინეკერი
Employees113 ათ.
Founded1 ოქტ. 1896
Headquartersბაზელი, ბაზელ-შტადტის კანტონი, შვეიცარია
SectorPharmaceutical industry
Websiteroche.com
Last report
23 აპრ. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -CHF
Revenue / Estimate
14,72 მლრდ./ (14,90 მლრდ. est.)CHF
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
15,92 მლრდ.
15,92 მლრდ.
15,75 მლრდ.
15,75 მლრდ.
Cost of goods sold
3,87 მლრდ.
3,87 მლრდ.
4,21 მლრდ.
4,21 მლრდ.
Cost of revenue
3,87 მლრდ.
3,87 მლრდ.
4,21 მლრდ.
4,21 მლრდ.
Research and development expenses
3,11 მლრდ.
3,11 მლრდ.
3,15 მლრდ.
3,15 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,29 მლრდ.
3,29 მლრდ.
3,59 მლრდ.
3,59 მლრდ.
Operating expense
6,30 მლრდ.
6,30 მლრდ.
6,82 მლრდ.
6,82 მლრდ.
Total operating expenses
10,17 მლრდ.
10,17 მლრდ.
11,03 მლრდ.
11,03 მლრდ.
Operating income
5,75 მლრდ.
5,75 მლრდ.
4,72 მლრდ.
4,72 მლრდ.
Other non operating income
4,00 მლნ.
4,00 მლნ.
-1,50 მლნ.
-1,50 მლნ.
EBT including unusual items
4,79 მლრდ.
4,79 მლრდ.
3,69 მლრდ.
3,69 მლრდ.
EBT excluding unusual items
5,46 მლრდ.
5,46 მლრდ.
4,37 მლრდ.
4,37 მლრდ.
Income tax expense
878,00 მლნ.
878,00 მლნ.
709,00 მლნ.
709,00 მლნ.
Effective tax rate
18,31%
18,31%
19,20%
19,20%
Other operating expenses
-110,50 მლნ.
-110,50 მლნ.
77,50 მლნ.
77,50 მლნ.
Net income
3,70 მლრდ.
3,70 მლრდ.
2,74 მლრდ.
2,74 მლრდ.
Net profit margin
23,27%
23,27%
17,36%
17,36%
Earnings per share
-
-
-
-
Interest and investment income
56,50 მლნ.
56,50 მლნ.
45,00 მლნ.
45,00 მლნ.
Interest expense
-304,00 მლნ.
-304,00 მლნ.
-289,50 მლნ.
-289,50 მლნ.
Net interest expenses
-247,50 მლნ.
-247,50 მლნ.
-244,50 მლნ.
-244,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
6,53 მლრდ.
6,53 მლრდ.
5,50 მლრდ.
5,50 მლრდ.
Gain or loss from assets sale
-
-
-21,50 მლნ.
-21,50 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer